MS pt. 2 Flashcards

1
Q

relapsing remitting MS (RRMS)

A

clear defined episodes of neurologic function followed by partial/complete recovery, with periods of time btw that pt’s are clinical free of disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

secondary progressive MS (SPMS)

A

can progress to this

initially presents as RR period followed by a steady worsening of neurologic fxn, with or without relapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do remissions look like with SPMS

A

minor or can have plateau
continue to get worse
can get missed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

primary progressive MS (PPMS)

A

continuous worsening from initial onset without distinct relapses or remission

may have occasional plateaus and temporary minor improvements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

acute exacerbation treatment

A

immunosuppressant drugs
prednisone, methylprednisone, adrenocorticotropic hormone (ACTH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what drugs are disease modifying

A

interferon drugs
copaxone
tysabri
novantrone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what do disease modifying drugs do

A

reduce frequency and severity of:
clinical attacks
reduce development of lesion sites
slow down the progression of disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do interferon drugs do

A

slow progression and decrease symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

side effects of interferon drugs

A

flu like symptoms
depression
abdominal pain
injxn site pain
leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

dosage for interferon drugs

A

daily
3x week
or weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dosage for copaxone

A

daily subcutaneous injxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does copaxone work

A

synthetic protein designed to mimic effects of myelin protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

side effects of copaxone

A

flu symptoms
N/V
joint pain
visual disturbances
weakness
edema in hands and feet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what systems does the expanded disability status scale look at

A

pyramidal
cerebellar
brainstem
sensory
bowel/bladder
visual
cerebral
other neurologic findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

normal to mild disability for EDSS

A

0-3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mild to moderate disability for EDSS

A

4-5.5

17
Q

mod to severe disability for EDSS

A

6-7.5

18
Q

severe disability with restriction to bed or WC for EDSS

A

8-9.5

19
Q

EDSS 0-4.5 clinical symptoms

A

no symptoms to mild to mod:

fatigue
unsteadiness/imbalance
sensory changes
mild walking impairments
reduced visual acuity
bowel/bladder symptoms
altered mood state
cog impairment

20
Q

EDSS 0-4.5 neurologic impairments

A

ranging from normal neurologic exam to mild-to-mod impairments in:

proprioception
cerebellar fxn
vision
muscle strength/tone/endurance
bladder fxn
cognition

21
Q

EDSS 0-4.5 functional limitations

A

ranging from no limitations to limited:

endurance
unsteadiness
impaired information processing and memory

22
Q

EDSS 5-6.5 symptoms

A

progression of any or all symptoms seen in 0-4.5

23
Q

EDSS 5-6.5 neurologic impairments

A

any symptoms mentioned with EDSS 0-4.5 plus:

worsening gait and UE coordination

24
Q

EDSS 5-6.5 functional limitations

A

limited walking distance 20-200m
falls
inability to safely complete dual motor/cognitive tasks
adaptive equipment at work/home
compensatory strategies
mobility aids
challenging transfers
requires assistance from support partner for more complex daily activities

25
Q

EDSS 7-9 symptoms

A

continued worsening gait of all symptoms mentioned with other levels

26
Q

EDSS 7-9 neurologic impairments

A

continued worsening symptoms mentioned with other levels

27
Q

EDSS 7-9 functional limitations

A

gait - 10ft w walker
transfers - minimal assist to total
bed mobility - minimal assist to total
seated balance - independent to total assist
standing balance - ind w bilateral support to unable to stand unaided